Discontinued — last reported Q1 '22
Medtronic Equity securities decreased by 12.3% to $50.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 56.3%, from $32.00M to $50.00M. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase reflects positive market performance of the underlying investments or additional capital deployment into equities.
This represents the fair market value of the company's investment portfolio consisting of equity securities in other ent...
Standard for companies with large corporate venture arms or significant treasury investment portfolios.
ins_equity_securities| Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $28.00M | $311.00M | $311.00M | $32.00M | $140.00M | $50.00M | $57.00M | $50.00M |
| QoQ Change | — | >999% | +0.0% | -89.7% | +337.5% | -64.3% | +14.0% | -12.3% |
| YoY Change | — | — | — | — | +400.0% | -83.9% | -81.7% | +56.3% |